Chemicals and Drugs

Biosimilar Pharmaceuticals

Biological products that are imitations but not exact replicas of innovator biological products.

National Library of MedicineMedical Subject Headings2026

Structured Summary

Abstract

Biological products that are imitations but not exact replicas of innovator biological products.

MeSH Record

Classification

Broader headings

Related Concepts

Knowledge Graph

Loading graph…

Drag nodes to rearrange; hover to trace links; click a node to open its page.

MeSH Record

Synonyms

8 entry terms
  • Follow-on Biologics
  • Subsequent Entry Biologics
  • Biologics, Follow-on
  • Biologics, Subsequent Entry
  • Follow on Biologics
  • Pharmaceuticals, Biosimilar
  • Biosimilar
  • Biosimilars

MeSH Record

Aspects Covered

21 allowable subheadings

Indexed with the subheadings administration & dosage, adverse effects, analysis, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, economics, history, isolation & purification, metabolism, pharmacokinetics, pharmacology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, urine.

MeSH Record

History Note

2012

MeSH Record

Previous Indexing

  • Biological Agents (2004-2011)

MeSH Hierarchy

Tree Number

  1. D20.215.261w

AMA Style

References

  1. National Library of Medicine. Biosimilar Pharmaceuticals. Medical Subject Headings (MeSH). 2026. Unique ID D059451. http://id.nlm.nih.gov/mesh/2026/D059451
  2. Biosimilar Pharmaceuticals. In: Wikipedia. https://en.wikipedia.org/wiki/Biosimilar
  3. Biosimilar Pharmaceuticals. In: Wikidata. https://www.wikidata.org/wiki/Q864715